Qiagen NV: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Avigen is a development stage biopharmaceutical company focusing on small molecule therapeutics and biologics to treat neurological and neuromuscular disorders. The company’s current pipeline products primarily address spasticity and neuromuscula

High impact company profile available at BioMarket

Anadys Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Nuvelo is a biopharmaceutical company that is focused on the discovery, development, and commercialization of novel drugs for acute cardiovascular and cancer therapy primarily in the US. The company’s lead candidate, NU172, is a Phase I product c

High impact company profile available at BioMarket

Bionovo Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

TomoTherapy Incorporated: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Founded in 1927, Zimmer Holdings is a diversified international orthopedic company with share leadership in multiple product categories including the $10 billion hip and knee replacement market.

High impact company profile available at BioMarket

Edwards Lifesciences Corp: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Poniard Pharmaceuticals, formerly known as NeoRx Corporation, is a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapy products. The company’s lead product candidate, Picoplatin, is currently in

High impact company profile available at BioMarket

High impact company profile available at BioMarket

Hologic Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

MannKind, a development-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic products for metabolical disorder and cancer. Technosphere Insulin (TI) System is the company’s lead product candidate in Pha

High impact company profile available at BioMarket

Noven Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Smith & Nephew is a diversified medical technology group specializing in orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management products. The group acquired two companies, Plus Orthopedics and

High impact company profile available at BioMarket

Analysis of GlaxoSmithKline’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

High impact company profile available at BioMarket

Targanta Therapeutics Corporation: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

La Jolla Pharmaceutical (La Jolla) is a development stage biotechnology company focused entirely on novel antibody therapies for specific autoimmune diseases. The company’s only clinical stage candidate, Riquent, is being studied in Phase III tri

High impact company profile available at BioMarket

AspenBio Pharma Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Antisoma is a development stage biotechnology company focused on the development of novel anticancer drugs. The Company has built a diversified product pipeline based on in-licensing and acquisitions that target a variety of tumors by different mechani

Optimer is a biopharmaceutical company focused on the discovery, development and global commercialization of anti-infective products for the treatment of serious infectious diseases. The Company currently has two late stage anti-infective product candi